Key result
Surgery and adjuvant chemotherapy yield 40-month survival in a patient with cardiac liposarcoma metastasis.
Case Report (n=1)
No
Surgical resection combined with postoperative chemotherapy may provide extended survival in patients with cardiac metastasis of liposarcoma.
May support multimodal therapy in rare cardiac liposarcoma metastases; leaves open need for prospective confirmation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hashiyama et al. (1999) conducted a case report in Cardiac metastasis of liposarcoma (n=1). Surgical resection and adjuvant chemotherapy was evaluated on Survival and clinical outcome. A combination of surgical resection and adjuvant chemotherapy yielded a long survival period of 40 months in good health for a patient with cardiac metastasis of liposarcoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: